Nathan A. Rohner
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 2
- Oncology 6
- Lymphatic System and Diseases 3
- Co-authors
- Susan N. Thomas (12 shared papers)Erin E. Edwards (1 shared paper)Horst A. von Recum (8 shared papers)Margaret P. Manspeaker (3 shared papers)David M. Francis (2 shared papers)Alex Schudel (2 shared papers)Mei‐Kwan Yau (1 shared paper)M. G. Finn (1 shared paper)
- Journals
- Macromolecular Bioscience (2 papers)Pharmaceutics (2 papers)ACS Biomaterials Science & Engineering (2 papers)Platelets (1 paper)Annual Review of Biomedical Engineering (1 paper)
- Partner nations
- United StatesSpainBelgium
In The Last Decade
Nathan A. Rohner
22 papers receiving 592 citations
Peers
Comparison fields: 5 of 87
- Immunology 220
- Biomaterials 117
- Pharmaceutical Science 50
- Oncology 194
- Biomedical Engineering 166
Countries citing papers authored by Nathan A. Rohner
This map shows the geographic impact of Nathan A. Rohner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan A. Rohner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan A. Rohner more than expected).
Fields of papers citing papers by Nathan A. Rohner
This network shows the impact of papers produced by Nathan A. Rohner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan A. Rohner. The network helps show where Nathan A. Rohner may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathan A. Rohner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 125 | |
| 2 | 2016 | 78 | |
| 3 | 2016 | 72 | |
| 4 | 2015 | 43 | |
| 5 | 2015 | 41 | |
| 6 | 2017 | 35 | |
| 7 | 2018 | 34 | |
| 8 | 2020 | 31 | |
| 9 | 2021 | 22 | |
| 10 | 2019 | 19 | |
| 11 | 2015 | 18 | |
| 12 | 2021 | 12 | |
| 13 | 2014 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2019 | 9 | |
| 16 | 2016 | 7 | |
| 17 | 2020 | 6 | |
| 18 | 2017 | 5 | |
| 19 | 2020 | 4 | |
| 20 | 2021 | 4 |
About Nathan A. Rohner
Nathan A. Rohner is a scholar working on Molecular Biology, Oncology, Immunology, Biomedical Engineering and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 594 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Inhalation and Respiratory Drug Delivery (3 papers), Lymphatic System and Diseases (3 papers), Wound Healing and Treatments (2 papers), Antimicrobial agents and applications (2 papers), Advanced Polymer Synthesis and Characterization (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Immunology (220 citations), Biomaterials (117 citations), Pharmaceutical Science (50 citations), Oncology (194 citations) and Biomedical Engineering (166 citations). Nathan A. Rohner has collaborated with scholars based in United States, Spain and Belgium. Frequent co-authors include Susan N. Thomas, Erin E. Edwards, Horst A. von Recum, Margaret P. Manspeaker, David M. Francis, Alex Schudel, Mei‐Kwan Yau, M. G. Finn, Cody J. Higginson and Meghan J. O’Melia. Their work appears in journals such as Macromolecular Bioscience, Pharmaceutics, ACS Biomaterials Science & Engineering, Platelets and Annual Review of Biomedical Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.